期刊文献+

NF-κB在铁负荷过低上调炎症因子中的作用

Effect of nuclear factor(NF)-κB on induction of EMMPRIN by excessive low iron load in macrophages and foam cells
下载PDF
导出
摘要 目的:探讨核转录因子(NF)-κB在铁负荷过低上调巨噬细胞、泡沫细胞炎症因子反应中的作用。方法:将巨噬细胞和泡沫细胞给予NF-κB抑制剂预处理,加入或不加入铁离子鳌合剂去铁胺(DFO)继续培养24 h,用West-ern blot测定细胞中细胞外基质金属蛋白酶诱导因子(EMMPRIN)蛋白的表达。于巨噬细胞和泡沫细胞中加入DFO刺激,用Western blot测定细胞核中NF-κB p65蛋白的表达。将巨噬细胞和泡沫细胞给予p38 MAPK信号通路抑制剂或视黄醛x受体(RXR)的天然配体预处理,加入DFO刺激,用Western blot测定细胞核中NF-κB p65蛋白的表达。结果:NF-κB抑制剂可抑制DFO对巨噬细胞、泡沫细胞中EMMPRIN上调的作用。DFO可促进巨噬细胞、泡沫细胞细胞核中NF-κB p65蛋白的表达。p38 MAPK通路抑制剂或RXR配体可抑制DFO对NF-κB p65蛋白水平上调的作用。结论:NF-κB参与了铁负荷过低上调巨噬细胞和泡沫细胞中EMMPRIN表达的过程。RXR配体对铁负荷过低上调炎症反应的抑制作用,同其抑制NF-κB激活有关。 AIM: To investigate the effect of NF-κB on the induction of EMMPRIN by excessive low iron load in macrophages and foam cells.METHODS: Thp-1 derived macrophages and foam cells were pre-treated with NF-κB inhibitor and then were stimulated with/without desferrioxamine(DFO) for 24 h.EMMPRIN expression was assayed by Western blot.Cells were stimulated with DFO for different time periods and nuclear NF-κB p65 protein levels were then assayed by Western blot.Cells were pre-treated with p38 MAPK inhibitors or RXR ligand and nuclear NF-κB p65 protein levels were assayed again by Western blot.RESULTS: NF-κB inhibitor blocked the induction of EMMPRIN by DFO stimulation,DFO enhanced nuclear NF-κB p65 protein levels in macrophages and foam cells and p38 MAPK inhibitor and RXR ligand significantly blocked DFO upregulation of NF-κB p65.CONCLUSION: NF-κB is involved not only in the excessive low iron load upregulation of EMMPRIN expression,but also in the RXR ligand downregulation of inflammatory factor in macrophages and foam cells.
出处 《心脏杂志》 CAS 2011年第2期205-208,共4页 Chinese Heart Journal
关键词 铁负荷过低 细胞外基质金属蛋白酶诱导因子 核转录因子-ΚB 动脉粥样硬化 excessive low iron load extracellular matrix metalloproteinase inducer nuclear factor-κB atherosclerosis
  • 相关文献

参考文献12

  • 1Thurberg BL, Collins T. The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis [ J ]. Curr Opin Lipidol, 1998, 9(5) :387 -396.
  • 2范虞琪,何奔,王彬尧.铁离子螯合剂去铁胺对巨噬细胞、泡沫细胞细胞外基质金属蛋白酶诱导因子表达的影响[J].心脏杂志,2009,21(5):601-605. 被引量:1
  • 3范虞琪,何奔,王彬尧.铁离子螯合剂去铁胺上调巨噬细胞、泡沫细胞细胞外基质金属蛋白酶诱导因子表达的机制探讨[J].心脏杂志,2009,21(6):757-760. 被引量:1
  • 4Schmidt R, Buhmann A, Ungerer M, et al. Extracellular matrix metalloproteinasc inducer regulates matrix metalloproteinase activity in cardiovascular ceils: implications in acute myocardial infarction [J]. Circulation, 2006, 113(6) :834 -841.
  • 5Huang Z, Wang C, Wei L, et al. Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMA-induced THP-1 cells[ J ]. Biochem Biophys Res Commun, 2008, 374 (3) : 517 - 521.
  • 6Lim M, Martinez T, Jablons D, et al. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collage- nase transcription through MAPK p38 [ J ]. FEBS Lett, 1998, 441 (1) :88 -92.
  • 7Hata K, Andoh A, Shimada M, et al. IL-17 stimulates inflammatory responses via NF- κB and MAP kinase pathways in human colonic myofibroblasts[ J ]. Am J Physiol Gastrointest Liver Physiol, 2002, 282 (6) : G1035 - G1044.
  • 8Marie C, Arielle M, Luise H, et al. Involvement of MAPK pathway in TNF-α -induced MMP-9 expression in human trophoblastic cells Molecular[ J]. Human Reproduction, 2006, 12(4) :225 -232.
  • 9Claudel T, Leibowitz MD, Fievet C, et al. Reduction of atheroscle- rosis in apolipoprotein E knockout mice by activation of the retinoid X receptor[J]. Proc Natl Acad Sci U S A, 2001, 98(5) :2610 - 2615.
  • 10Lalloyer F, Fievet C, Lestavel S, et al. The RXR agonist bexarotene improves cholesterol homeostasis and inhibits atherosclerosis progres- sion in a mouse model of mixed dyslipidemia[ J]. Arterioscler Thromb Vasc Biol, 2006, 26(12):2731 -2737.

二级参考文献18

  • 1何清,王长谦,葛恒,郭炳诗,何奔.特异性抑制单核细胞中EMMPRIN基因表达的siRNA筛选和鉴定[J].上海交通大学学报(医学版),2007,27(6):681-684. 被引量:5
  • 2sullivan JL. Iron and sex difference in heart disease risk[J]. Lancet, 1981, 1(8233):1293-1294.
  • 3Hansson GK. Inflammation,athemsclemsis,and coronary artery disease[J]. N Engl J Med, 2005, 352(16):1685-1695.
  • 4Inokubo Y, Hanada H, Ishizaka H, et al. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome[J]. Am Heart J, 2001, 141(2):211-217.
  • 5Schmidt R, Bultmann A, Ungerer M, et al. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction[J]. Circulation, 2006, 113(6):834-841.
  • 6Schmidt R, Bultmann A, Fischel S, et al. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes[J]. Circ Res, 2008, 102(2):302-309.
  • 7Duffy SJ, Biegelsen ES, Holbrook M, et al. Iron chelation improves endothelial function in patients with coronary artery disease[J]. Circulation, 2001, 103(23):2799-2804.
  • 8Choi EY, Kim EC, Oh HM, et al. Iron chelator triggers inflammatory signals in human intestinal epithelial cells: involvement of p38 and extracellular signal-regulated kinase signaling pathways[J]. J Immunol, 2004, 172(11):7069-7077.
  • 9Lee SK, Lee J, Min SK, et al. Iron chelator differentially activates macrophage inflammatory protein-3alpha/CCL20 in immortalized and malignant human oral keratinocytes[J]. Arch Oral Biol, 2008, 53(9):801-809.
  • 10Kaomongkolgit R, Cheepsunthorn P, Pavasant P, et al. Iron increases MMP-9 expression through activation of AP-1 via ERK/Akt pathway in human head and neck squamous carcinoma cells[J]. Oral Oncol, 2008, 44(6):587-594.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部